• 1:头版
  • 2:财经要闻
  • 3:焦点
  • 4:金融·证券
  • 5:上市公司
  • 6:产业·公司
  • 8:书评
  • 9:信息大全
  • 10:信息披露
  • 11:信息披露
  • 12:信息披露
  • 13:信息披露
  • 14:信息披露
  • 15:信息披露
  • 16:信息披露
  • 17:信息披露
  • 18:信息披露
  • 19:信息披露
  • 20:信息披露
  • 21:信息披露
  • 22:信息披露
  • 23:信息披露
  • 24:信息披露
  • 25:信息披露
  • 26:信息披露
  • 27:信息披露
  • 28:信息披露
  • 29:信息披露
  • 30:信息披露
  • 31:信息披露
  • 32:信息披露
  • 33:信息披露
  • 34:信息披露
  • 35:信息披露
  • 36:信息披露
  • 37:信息披露
  • 38:信息披露
  • 39:信息披露
  • 40:信息披露
  • 41:信息披露
  • 42:信息披露
  • 43:信息披露
  • 44:信息披露
  • 45:信息披露
  • 46:信息披露
  • 47:信息披露
  • 48:信息披露
  • 49:信息披露
  • 50:信息披露
  • 51:信息披露
  • 52:信息披露
  • 53:信息披露
  • 54:信息披露
  • 55:信息披露
  • 56:信息披露
  • 57:信息披露
  • 58:信息披露
  • 59:信息披露
  • 60:信息披露
  • 61:信息披露
  • 62:信息披露
  • 64:信息披露
  • 65:信息披露
  • 66:信息披露
  • 67:信息披露
  • 68:信息披露
  • 69:信息披露
  • 70:信息披露
  • 71:信息披露
  • 72:信息披露
  • 73:信息披露
  • 74:信息披露
  • 75:信息披露
  • 76:信息披露
  • 77:信息披露
  • 78:信息披露
  • 79:信息披露
  • 80:信息披露
  • 81:信息披露
  • 82:信息披露
  • 83:信息披露
  • 84:信息披露
  • 85:信息披露
  • 86:信息披露
  • 87:信息披露
  • 88:信息披露
  • T1:艺术财经
  • T2:艺术财经·市场
  • T3:艺术财经·焦点
  • T4:艺术财经·专题
  • T5:艺术财经·专题
  • T6:艺术财经·收藏
  • T7:艺术财经·资讯
  • T8:艺术财经·人物
  •  
      2009 8 15
    前一天  
    按日期查找
    66版:信息披露
    上一版  下一版  
    pdf
     
     
     
      | 66版:信息披露
    云南白药集团股份有限公司2009年半年度报告摘要
    云南白药集团股份有限公司
    董事会2009年度第二次会议决议公告
    更多新闻请登陆中国证券网〉〉〉
     
     
    上海证券报网络版郑重声明
       经上海证券报社授权,中国证券网独家全权代理《上海证券报》信息登载业务。本页内容未经书面授权许可,不得转载、复制或在非中国证券网所属服务器建立镜像。欲咨询授权事宜请与中国证券网联系 (400-820-0277) 。

     
    标题: 作者: 正文: 起始时间: 截止时间:
      本版导航 | 版面导航 | 标题导航 收藏 | 打印 | 推荐  
    云南白药集团股份有限公司2009年半年度报告摘要
    2009年08月15日      来源:上海证券报      作者:
      合并所有者权益变动表

      编制单位:云南白药集团股份有限公司                                                                                                                                                                            2009半年度                        单位:(人民币)元

      母公司所有者权益变动表

      编制单位:云南白药集团股份有限公司                                                                                                                                                                             2009半年度                                            单位:(人民币)元

      证券代码:000538                            证券简称:云南白药                            公告编号:2009-035

      云南白药集团股份有限公司

      2009年半年度报告摘要

      §1 重要提示

      1.1 本公司董事会、监事会及其董事、监事、高级管理人员保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性负个别及连带责任。

      本半年度报告摘要摘自半年度报告全文,报告全文同时刊载于巨潮资讯网(www.cninfo.com.cn)。投资者欲了解详细内容,应当仔细阅读半年度报告全文。

      1.2 公司半年度财务报告未经会计师事务所审计。

      1.3 公司董事长王明辉、总经理尹品耀及财务总监吴伟声明:保证半年度报告中财务报告的真实、完整。

      §2 上市公司基本情况

      2.1 基本情况简介

      ■

      2.2 主要财务数据和指标

      2.2.1 主要会计数据和财务指标

      单位:(人民币)元

      ■

      2.2.2 非经常性损益项目

      √ 适用 □ 不适用

      单位:(人民币)元

      ■

      2.2.3 境内外会计准则差异

      □ 适用 √ 不适用

      §3 股本变动及股东情况

      3.1 股份变动情况表

      √ 适用 □ 不适用

      单位:股

      ■

      3.2 前10名股东、前10名无限售条件股东持股情况表

      单位:股

      ■

      3.3 控股股东及实际控制人变更情况

      □ 适用 √ 不适用

      §4 董事、监事和高级管理人员情况

      4.1 董事、监事和高级管理人员持股变动

      √ 适用 □ 不适用

      ■

      §5 董事会报告

      5.1 主营业务分行业、产品情况表

      单位:(人民币)万元

      ■

      其中:报告期内上市公司向控股股东及其子公司销售产品和提供劳务的关联交易总金额为0.00万元

      5.2 主营业务分地区情况

      单位:(人民币)万元

      ■

      5.3 主营业务及其结构发生重大变化的原因说明

      □ 适用 √ 不适用

      5.4 主营业务盈利能力(毛利率)与上年相比发生重大变化的原因说明

      □ 适用 √ 不适用

      5.5 利润构成与上年度相比发生重大变化的原因分析

      □ 适用 √ 不适用

      5.6 募集资金使用情况

      5.6.1 募集资金运用

      √ 适用 □ 不适用

      单位:(人民币)万元

      ■

      5.6.2 变更项目情况

      □ 适用 √ 不适用

      5.7 董事会下半年的经营计划修改计划

      □ 适用 √ 不适用

      5.8 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生大幅度变动的警示及原因说明

      □ 适用 √ 不适用

      5.9 公司董事会对会计师事务所本报告期“非标准审计报告”的说明

      □ 适用 √ 不适用

      5.10 公司董事会对会计师事务所上年度“非标准审计报告”涉及事项的变化及处理情况的说明

      □ 适用 √ 不适用

      §6 重要事项

      6.1 收购、出售资产及资产重组

      6.1.1 收购资产

      □ 适用 √ 不适用

      6.1.2 出售资产

      □ 适用 √ 不适用

      6.1.3 自资产重组报告书或收购出售资产公告刊登后,该事项的进展情况及对报告期经营成果与财务状况的影响

      □ 适用 √ 不适用

      6.2 担保事项

      □ 适用 √ 不适用

      6.3 非经营性关联债权债务往来

      □ 适用 √ 不适用

      6.4 重大诉讼仲裁事项

      □ 适用 √ 不适用

      6.5 其他重大事项及其影响和解决方案的分析说明

      □ 适用 √ 不适用

      6.5.1 证券投资情况

      □ 适用 √ 不适用

      6.5.2 持有其他上市公司股权情况

      □ 适用 √ 不适用

      6.5.3 2009半年度资金被占用情况及清欠进展情况

      □适用 √不适用

      独立董事对公司关联方资金占用和对外担保情况的专项说明和独立意见

      根据《关于在上市公司建立独立董事的指导意见》、中国证监会证监发[2003]56号《关于规范上市公司与关联方资金往来及上市公司对外担保若干问题的通知》的规定,作为云南白药集团股份有限公司(以下简称“公司”)的独立董事,我们对控股股东及其他关联方占用公司资金以及公司对外担保情况进行了核查,发表专项说明和独立意见如下:

      截止 2009年6月30 日,公司在本报告期内没有发生对外担保、违规对外担保、控股股东及其他关联方违规占用公司资金等情况,也不存在以前年度发生但延续到本报告期的对外担保、违规对外担保、控股股东及其他关联方违规占用公司资金等情况。

      6.5.4 公司及股东、董事、监事、高级管理人员履行承诺情况

      √ 适用 □ 不适用

      ■

      6.6 报告期接待调研、沟通、采访等活动情况表

      ■

      ■

      §7 财务报告

      7.1 审计意见

      ■

      7.2 财务报表

      7.2.1 资产负债表

      编制单位:云南白药集团股份有限公司         2009年06月30日                    单位:(人民币)元

      ■

      ■

      (下转68版)

                                                                            

    项目本期金额上年金额
                                                                

    归属于母公司所有者权益少数股东权益所有者权益合计归属于母公司所有者权益少数股东权益所有者权益合计
                                                                                                                         (或股本)                                                                                         他        

    实收资本            资本公积减:库存股专项储备盈余公积一般风险准备未分配利润其他实收资本            资本公积减:库存股专项储备盈余公积一般风险准备未分配利润其            

        (或股本)

                                                            

                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                         

                                                                                                                                                                                                                         

                                                            

                                                                      

                                                                                                                                                                                

                                                                                                                                                                                   

                                                                                                                                                                                   

                                                                                                                                                                                                                         

                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                    

                                                                                                                           

                                                                                                                                                             

                                                                                                                                                                      

                                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                            

                                                                                                                                                                           

                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                        

                                                                                                                                                                                  

                                                                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                    

                                                            

    一、上年年末余额534,051,138.001,397,057,201.89217,704,428.06988,431,962.7949,391,707.933,186,636,438.67484,051,138.0063,763,970.11170,937,201.17628,441,433.5977,578,876.451,424,772,619.32
    加:会计政策变更-382,711.08-3,444,399.76-3,827,110.84
    前期差错更正-3,760,025.953,760,025.95
    其他86,646,352.229,376,205.29-15,806,380.0480,216,177.47
    二、本年年初余额534,051,138.001,397,057,201.89217,704,428.06988,431,962.7949,391,707.933,186,636,438.67484,051,138.00150,410,322.33176,170,669.43612,950,679.7477,578,876.451,501,161,685.95
    三、本年增减变动金额(减少以“-”号填列)-2,476,063.21106,075,242.391,092,006.62104,691,185.8050,000,000.001,246,646,879.5641,533,758.63375,481,283.05-28,187,168.521,685,474,752.72
    (一)净利润266,290,583.791,092,006.62267,382,590.41465,420,155.48-1,888,332.56463,531,822.92
    (二)直接计入所有者权益的利得和损失-2,121,730.90-2,121,730.90-17,337,119.44-17,337,119.44
    1.可供出售金融资产公允价值变动净额-2,121,730.90-2,121,730.90-6,877,248.00-6,877,248.00
    2.权益法下被投资单位其他所有者权益变动的影响-11,491,458.64-11,491,458.64
    3.与计入所有者权益项目相关的所得税影响1,031,587.201,031,587.20
    4.其他
    上述(一)和(二)小计-2,121,730.90266,290,583.791,092,006.62265,260,859.51-17,337,119.44465,420,155.48-1,888,332.56446,194,703.48
    (三)所有者投入和减少资本-354,332.31-354,332.3150,000,000.001,263,983,999.00-13,498,205.971,300,485,793.03
    1.所有者投入资本-354,332.31-354,332.3150,000,000.001,313,984,000.00-13,498,205.971,350,485,794.03
    2.股份支付计入所有者权益的金额
    3.其他-50,000,001.00-50,000,001.00
    (四)利润分配-160,215,341.40-160,215,341.4041,533,758.63-89,938,872.43-12,800,629.99-61,205,743.79
    1.提取盈余公积41,533,758.63-41,533,758.63
    2.提取一般风险准备
    3.对所有者(或股东)的分配-160,215,341.40-160,215,341.40-48,405,113.80-12,739,598.88-61,144,712.68
    4.其他-61,031.11-61,031.11
    (五)所有者权益内部结转
    1.资本公积转增资本(或股本)
    2.盈余公积转增资本(或股本)
    3.盈余公积弥补亏损
    4.其他
    四、本期期末余额534,051,138.001,394,581,138.68217,704,428.061,094,507,205.1850,483,714.553,291,327,624.47534,051,138.001,397,057,201.89217,704,428.06988,431,962.7949,391,707.933,186,636,438.67

                                                    

    项目本期金额上年金额
        

    实收资本(或股本)资本公积减:库存股专项储备盈余公积未分配利润所有者权益合计实收资本(或股本)资本公积减:库存股专项储备盈余公积未分配利润所有者权益合计
                                            

                                                                                                                                                                                

                                                                                                                                                                                    

                                                                                                                                                                                                                                    

                                            

                                                      

                                                                                                                                                                

                                                                                                                                   

                                                                                                                                   

                                                                                                                                                                                                

                                                                                                                                                                         

                                                                                                                                                               

                                                                                                          

                                                                                                                                                                     

                                                                                                                                                                             

                                                                                                                                                                                                        

                                                                                                                                                                                                                                

                                                                                                                                         

                                                                                                                                                                                     

                                                                                                                                                 

                                                                                                                                                                                                                                

                                                                                                                                                                                                                

                                                                                                                                                                                                            

                                                                                                                                                                                                            

                                                                                                                                                                                                                    

                                                                                                                                                                                                                                

                                            

    一、上年年末余额534,051,138.001,376,653,327.30208,328,222.77654,570,143.982,773,602,832.05484,051,138.0040,039,160.22170,937,201.17366,456,063.411,061,483,562.80
    加:会计政策变更-382,711.08-3,444,399.76-3,827,110.84
    前期差错更正-3,760,025.95-33,840,233.54-37,600,259.49
    其他
    二、本年年初余额534,051,138.001,376,653,327.30208,328,222.77654,570,143.982,773,602,832.05484,051,138.0040,039,160.22166,794,464.14329,171,430.111,020,056,192.47
    三、本年增减变动金额(减少以“-”号填列)-7,121,730.90-68,863,892.92-75,985,623.8250,000,000.001,336,614,167.0841,533,758.63325,398,713.871,753,546,639.58
    (一)净利润91,351,448.4891,351,448.48415,337,586.30415,337,586.30
    (二)直接计入所有者权益的利得和损失-7,121,730.90-7,121,730.9022,630,167.0822,630,167.08
    1.可供出售金融资产公允价值变动净额-2,121,730.90-2,121,730.90-6,877,248.00-6,877,248.00
    2.权益法下被投资单位其他所有者权益变动的影响
    3.与计入所有者权益项目相关的所得税影响1,031,587.201,031,587.20
    4.其他-5,000,000.00-5,000,000.0028,475,827.8828,475,827.88
    上述(一)和(二)小计-7,121,730.9091,351,448.4884,229,717.5822,630,167.08415,337,586.30437,967,753.38
    (三)所有者投入和减少资本50,000,000.001,313,984,000.001,363,984,000.00
    1.所有者投入资本50,000,000.001,313,984,000.001,363,984,000.00
    2.股份支付计入所有者权益的金额
    3.其他
    (四)利润分配-160,215,341.40-160,215,341.4041,533,758.63-89,938,872.43-48,405,113.80
    1.提取盈余公积41,533,758.63-41,533,758.63
    2.对所有者(或股东)的分配-160,215,341.40-160,215,341.40-48,405,113.80-48,405,113.80
    3.其他
    (五)所有者权益内部结转
    1.资本公积转增资本(或股本)
    2.盈余公积转增资本(或股本)
    3.盈余公积弥补亏损
    4.其他
    四、本期期末余额534,051,138.001,369,531,596.40208,328,222.77585,706,251.062,697,617,208.23534,051,138.001,376,653,327.30208,328,222.77654,570,143.982,773,602,832.05